Novel Prostate Cancer Risk Classifier Highly Prognostic for Metastases

Video

This video highlights a clinical-genomic risk classification system that is highly prognostic for distant metastasis and more accurate than clinical risk assessments.

Daniel Eidelberg Spratt, MD, on a Novel Clinical-Genomic Risk Group Classifier for Prostate Cancer
Video Player is loading.
Current Time 0:00
Duration 4:31
Loaded: 3.63%
Stream Type LIVE
Remaining Time 4:31
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    In this video, Daniel Eidelberg Spratt, MD, of the University of Michigan, discusses how the use of a readily available genomic classifier combined with clinicopathologic variables can generate a simple to use clinical-genomic risk classification system that is highly prognostic for distant metastasis and more accurate than clinical risk assessments.

    Spratt presented results of the study (abstract 5000) at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2–6 in Chicago.

    Related Content